GLAND.NS
GLAND.NS
INE068V01023
GLAND PHARMA LIMITED
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Market & Enterprise Value
Market Cap
505.23B EUR
411.24B EUR
279.44B EUR
Enterprise Value
473.7B EUR
411.24B EUR
248.69B EUR
Valuation Multiples
Trailing P/E
44.72x
35.43x
27.13x
Forward P/E
31.78x
--
--
Price to Sales
7.51x
6.1x
4.39x
Price to Book
4.87x
--
2.7x
EV/Revenue
7.04x
6.1x
3.9x
EV/EBITDA
27.54x
19.6x
12.82x
Price to FCF (P/FCF)
--
--
--
EV/FCF
--
--
--
FCF Yield
--
--
--
ende